P53 Therapeutics - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeP53 Therapeutics
P53 Therapeutics logo

P53 Therapeutics

0 followers

About P53 Therapeutics

P53 Therapeutics is a biotechnology company headquartered in Philadelphia, Pennsylvania that develops small‑molecule cancer therapeutics aimed at bypassing or restoring the function of the mutated p53 tumor‑suppressor gene. The company focuses on precision oncology, genomic medicine, and strategies to overcome drug resistance, advancing a pipeline of innovative treatments through collaboration with academic and industry partners.

Recent News

No recent news for this company.

Recent Deals

Key Facts

HQ Location

Philadelphia, United States

Founded

2013

Employees

1 - 10

Status

Private

Website

https://p53-therapeutics.com